# Parsolex expands cGMP manufacturing capacity in West Lafayette, Indiana

Parsolex has begun a capital investment program to expand its cGMP processing space by 33%, increase its analytical laboratory footprint by 50%, and add two new product-development suites at its facility in West Lafayette, Indiana.

- Type: Expansion
- Announced: 2020-03-06
- Where: West Lafayette, Indiana, United States
- Status: announced
- Capacity: 33% increase in cGMP processing space
- Products: pharmaceutical tablets, capsules, liquids
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Parsolex](https://endata.com/companies/45777.md)

## Sources

- [tabletscapsules.com](https://www.tabletscapsules.com/3641-Technical-Articles/585024-Industry-Application-Parsolex-expands-manufacturing-capabilities/), 2020-03-06: "This flexibility has allowed us to maintain tableting, liquid, and automated capsule-filling technology to support both clinical and commercial production."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.